Evidence map›Paper›PMID 35986143›Full record

ArticlePediatric research2023

SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy.

Jenny C Jin, Aparna Ananthanarayanan, Julia A Brown, Stephanie L Rager, Yaron Bram, Katherine Z Sanidad, Mohammed Amir, Rebecca N Baergen, Heidi Stuhlmann, Robert E Schwartz and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jenny C JinDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
Aparna AnanthanarayananDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
Julia A BrownDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
Stephanie L RagerDepartment of Pediatrics, Division of Newborn Medicine, New York-Presbyterian-Weill Cornell Medicine, New York, NY, USA.
Yaron BramDivision of Gastroenterology and Hepatology, Department of Medicine, New York-Presbyterian-Weill Cornell Medicine, New York, NY, USA.
Katherine Z SanidadDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
Mohammed AmirDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
Rebecca N BaergenDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Heidi StuhlmannDepartment of Pediatrics, Division of Newborn Medicine, New York-Presbyterian-Weill Cornell Medicine, New York, NY, USA.
Robert E SchwartzDivision of Gastroenterology and Hepatology, Department of Medicine, New York-Presbyterian-Weill Cornell Medicine, New York, NY, USA.
Jeffrey M PerlmanDepartment of Pediatrics, Division of Newborn Medicine, New York-Presbyterian-Weill Cornell Medicine, New York, NY, USA.
Melody Y ZengDrukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA. myz4001@med.cornell.edu.
Cornell University · USWeill Cornell Medicine · USPresbyterian Hospital · US

Funding

Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyteR01DK121072 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2020 to 2024
$2.6M
Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cellsR01CA234614 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHWARTZ, ROBERT E · 2019 to 2023
$1.9M
Role of gut microbiota-induced IgG in enteric host defenseK01DK114376 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZENG, MELODY Y · 2018 to 2022
$758k
NCI NIH HHS R01 CA234614NIAID NIH HHS R01 AI107301NIDDK NIH HHS K01 DK114376NIDDK NIH HHS R01 DK121072
6 · The paper itself

Abstract

backgroundIn utero transmission of SARS coronavirus 2 (SARS-CoV-2) has not been fully investigated. We investigated whether newborns of mothers with COVID-19 during pregnancy might harbor SARS-CoV-2 in the gastrointestinal tract.

methodsThis cohort study investigated stool from 14 newborns born at 25-41 weeks admitted at delivery to our urban academic hospital whose mothers had COVID-19 during pregnancy. Eleven mothers had COVID-19 resolved more than 10 weeks before delivery. Newborn stool was evaluated for SARS-CoV-2 RNA, Spike protein, and induction of inflammatory cytokines interleukin-6 (IL-6) and interferon-γ (IFN-γ) in macrophages.

resultsDespite negative SARS CoV-2 nasal PCRs from all newborns, viral RNAs and Spike protein were detected in the stool of 11 out of 14 newborns as early as the first day of life and increased over time in 6. Stool homogenates from all 14 newborns elicited elevated inflammatory IL-6 and IFN-γ from macrophages. Most newborns were clinically well except for one death from gestational autoimmune liver disease and another who developed necrotizing enterocolitis.

conclusionsThese findings suggest in utero transmission of SARS-CoV-2 and possible persistent intestinal viral reservoirs in the newborns. Further investigation is required to understand the mechanisms and their clinical implications. IMPACT: SARS-CoV-2 RNAs or Spike protein was detected in the stool of 11 out of 14 preterm newborns born to mothers with resolved COVID-19 weeks prior to delivery despite negative newborn nasal PCR swabs. These novel findings suggest risk of in utero SARS-CoV-2 transmission to the fetal intestine during gestation. The presence of SARS-CoV-2 RNAs and Spike protein in the intestines of newborns may potentially impact the development of the gut microbiome and the immune system; the long-term health impact on the preterm infants should be further investigated.

Indexed as

COVID-19Pregnancy Complications, InfectiousCohort StudiesFemaleHumansInfant, NewbornInfant, PrematureInfectious Disease Transmission, VerticalInterleukin-6PregnancyRNA, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusInterleukin-6RNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35986143
PMCPMC9388973
OpenAlexW4292400103

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.